Icatibant Acetate
- CAS No.
- 138614-30-9
- Chemical Name:
- Icatibant Acetate
- Synonyms
- Firazyr;CS-1399;HOE 140 Acetate;Arteband Acetate;lcatibant Acetate;Aldeibant acetate;Etibatide acetate;Icatibant Acetate;HOE-140 (Icatibant);Etiban acetate salt
- CBNumber:
- CB5497052
- Molecular Formula:
- C59H89N19O13S.C2H4O2
- Molecular Weight:
- 1364.59
- MDL Number:
- MFCD04112967
- MOL File:
- 138614-30-9.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| storage temp. | -20°C |
|---|---|
| solubility |
DMSO:65.0(Max Conc. mg/mL);47.63(Max Conc. mM) Ethanol:0.25(Max Conc. mg/mL);0.18(Max Conc. mM) PBS (pH 7.2):10.0(Max Conc. mg/mL);7.33(Max Conc. mM) |
| form | A crystalline solid |
| color | White to off-white |
| InChIKey | HKMZRZUEADSZDQ-SUJPMXFINA-N |
| FDA UNII | 325O8467XK |
| UNSPSC Code | 51111800 |
| NACRES | NA.32 |
SAFETY
Risk and Safety Statements
| PPE | Eyeshields, Gloves, type N95 (US) |
|---|---|
| WGK Germany | 3 |
| Storage Class | 11 - Combustible Solids |
Icatibant Acetate price More Price(56)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | H157 | HOE 140 ≥94% | 138614-30-9 | 250μg | $358 | 2026-04-30 | Buy |
| Cayman Chemical | 24083 | Icatibant (acetate) ≥98% | 138614-30-9 | 500μg | $90 | 2026-04-30 | Buy |
| Cayman Chemical | 24083 | Icatibant (acetate) ≥98% | 138614-30-9 | 1mg | $158 | 2026-04-30 | Buy |
| Cayman Chemical | 24083 | Icatibant (acetate) ≥98% | 138614-30-9 | 5mg | $479 | 2026-04-30 | Buy |
| Usbiological | 452174 | Icatibant Acetate (HOE 140) ≥98%(HPLC,TLC) | 138614-30-9 | 1mg | $472 | 2026-06-03 | Buy |
Icatibant Acetate Chemical Properties, Uses, Production
Description
Although it is a rare disease, HAE is an autosomal dominant disorder that can be potentially life-threatening when swelling manifests itself within the upper airways. Antagonism of the constitutively expressed B2 receptor, therefore, would not only be beneficial in the treatment of HAE but also find application in inflammatory, allergic, and hyperalgesic disorders.Designed to possess enhanced metabolic stability with the inclusion of five non-proteinogenic amino acids, icatibant is a competitive and selective B2 receptor antagonist (devoid of activity against the inducible B1 receptor) with a Ki of 2.2±0.7 nM, and it is the first downstream targeting agent to receive regulatory approval. It joins purified C1 esterase inhibitor, danazol (an attenuated androgen), and tranexamic acid (an antifibrinolytic agent) as acute and prophylactic treatments for HAE.
Originator
Jerini (Germany)
Uses
Antagonist (bradykinin).
Uses
Icatibant Acetate is a bradykinin B2 receptor antagonist that has been recently approved for treatment of acute attacks of hereditary angioedema (HAE).
Definition
ChEBI: An acetate salt obtained by combining icatibant with acetic acid. Used for the treatment of acute attacks of hereditary angioedema in adult patients.
brand name
Metastat (CollaGenex);Firazyr.
Biochem/physiol Actions
B2 bradykinin receptors are present in the sensory neurons. Activation of B2 receptor by bradykinin is associated with pro-inflammatory, pain producing and cardiovascular responses. HOE-140 is a selective B2 bradykinin receptor antagonist. Presence of HOE-140 suppresses the effects of bradykinin and has been shown to have anti-hyperalgesic response, particularly towards inflammatory pain.
Synthesis
The peptidomimetic is prepared by standard solidphase technology on Wang resin employing Fmoc chemistry. Following trifluoroacetic acid cleavage with appropriate scavengers and HPLC purification, icatibant is ultimately isolated as its acetate salt.
Icatibant Acetate Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| GL Biochem (Shanghai) Ltd | 21-61263452 13641803416 | ymbetter@glbiochem.com | China | 9981 | 64 |
| Adamas Reagent, Ltd. | 4006009262 13023226327 | hmj@titansci.com | China | 14098 | 59 |
| Chemsky(shanghai)International Co.,Ltd. | 021-50135380 | shchemsky@sina.com | China | 32273 | 50 |
| Guangzhou Isun Pharmaceutical Co., Ltd | 020-39119399 18927568969 | isunpharm@qq.com | China | 4773 | 55 |
| Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632; | sales@reading-chemicals.com | China | 15165 | 58 |
| Sigma-Aldrich | 021-61415566 800-8193336 | orderCN@merckgroup.com | China | 51389 | 80 |
| Shanghai Haozhixiang Biotechnology Co., Ltd | 526763801 13301653310 | 526763801@qq.com | China | 7997 | 55 |
| Avantpbc Chemical Tech(Shanghai) Co,Ltd. | 17802107445 | China | 185 | 55 | |
| Shanghai YuanYe Biotechnology Co., Ltd. | 18916372613 | yanzihan@shyuanye.com | China | 87240 | 60 |
View Latest Price from Icatibant Acetate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-10-13 | HOE-140
138614-30-9
|
$1.00 | 1g | 99% | 100kg | RongNa Biotechnology Co.,Ltd | |
![]() |
2026-10-13 | HOE-140
138614-30-9
|
1g | 98%min | 1000g | WUHAN FORTUNA CHEMICAL CO., LTD | ||
![]() |
2026-09-29 | Icatibant Acetate
138614-30-9
|
1g | >=99% (HPLC), USP43 | 10000000g | Chengdu Shengnuo Biopharm Co.,Ltd |
-

- HOE-140
138614-30-9
- $1.00
- 99%
- RongNa Biotechnology Co.,Ltd
-

- HOE-140
138614-30-9
- $0.00
- 98%min
- WUHAN FORTUNA CHEMICAL CO., LTD
-

- Icatibant Acetate
138614-30-9
- >=99% (HPLC), USP43
- Chengdu Shengnuo Biopharm Co.,Ltd




